ABVC BioPharma (ABVC) Institutional Ownership $2.97 +0.03 (+1.02%) Closing price 08/13/2025 04:00 PM EasternExtended Trading$2.90 -0.07 (-2.49%) As of 08/13/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ABVC BioPharma (NASDAQ:ABVC)CurrentInstitutional OwnershipPercentage11.38%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$102.88KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$17.35K Get ABVC Insider Trade Alerts Want to know when executives and insiders are buying or selling ABVC BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABVC Institutional Buying and Selling by Quarter ABVC BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2025 XTX Topco Ltd52,625$117K0.0%-12.9%0.310% 8/8/2025 Geode Capital Management LLC110,499$246K0.0%+5.8%0.651% 5/8/2025 XTX Topco Ltd60,439$64K0.0%+75.7%0.360% 2/7/2025 Avantax Planning Partners Inc.143,968$85K0.0%+269.1%1.110% 5/2/2024 Chase Investment Counsel Corp178,377$233K0.1%N/A1.689% 11/16/2021Squarepoint Ops LLC19,207$44K0.0%N/A0.072% 11/12/2021Credit Suisse AG11,709$27K0.0%N/A0.044% (Data available from 1/1/2016 forward) ABVC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABVC shares? During the previous two years, the following institutional investors and hedge funds held shares of ABVC BioPharma shares: Geode Capital Management LLC ($246K), Chase Investment Counsel Corp ($233K), and XTX Topco Ltd ($117K), Avantax Planning Partners Inc. ($85K).Learn more on ABVC BioPharma's institutional investors. What percentage of ABVC BioPharma's stock is owned by institutional investors? 11.38% of ABVC BioPharma's stock is owned by institutional investors. Learn more on ABVC's institutional investor holdings. Which institutional investors have been buying ABVC BioPharma's stock? The following institutional investors have purchased ABVC BioPharma's stock in the last 24 months: Chase Investment Counsel Corp ($178.38K), Avantax Planning Partners Inc. ($104.97K), XTX Topco Ltd ($26.03K), and Geode Capital Management LLC ($6.02K). How much institutional buying is happening at ABVC BioPharma? Institutional investors have bought a total of 137,019 shares in the last 24 months. This purchase volume represents approximately $102.88K in transactions. Which of ABVC BioPharma's major shareholders have been selling company stock? The following institutional investors have sold ABVC BioPharma stock in the last 24 months: XTX Topco Ltd ($7.81K). How much institutional selling is happening at ABVC BioPharma? Institutional investors have sold a total of 7,814 shares in the last 24 months. This volume of shares sold represents approximately $17.35K in transactions. Related Companies enGene Institutional Ownership Aerovate Therapeutics Institutional Ownership Innate Pharma Institutional Ownership MediWound Institutional Ownership GENFIT Institutional Ownership DiaMedica Therapeutics Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership CytomX Therapeutics Institutional Ownership Caribou Biosciences Institutional Ownership Eledon Pharmaceuticals Institutional Ownership This page (NASDAQ:ABVC) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredD.C.’s secret plan to crush the debt.At a recent gathering with some of the most powerful people in America, Jeff discovered the Trump administrati...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access